As the co-founder and Chief Executive Officer of Medable, Dr. Michelle Longmire is mission-driven to
accelerate the development of new therapies for disease. A Stanford-trained physician-scientist, Dr.
Longmire witnessed firsthand the critical barriers to drug development – including the time and
costs associated with clinical trial participation. She founded Medable to pioneer a new category of
clinical trial technologies that remove traditional roadblocks to participation and radically accelerate
the research process. Medable is now the industry leader in decentralized and direct-to-patient
research, with the ability to serve patients in over 120 languages, 60 countries, and across all
therapeutic areas. In addition to having raised over $500M in venture capital and driving Medable to
an industry-leading position, Dr. Longmire has received recognition as a leading innovator and
businesswoman, including being named as one of the 100 most creative people in business by Fast
Company.